converting between glp-1 agonists dose conversion chart and safe switching guide Evolution of GLP‐1 Receptor Agonists

Description

(Open access) See more from MedicalBrief archives: Boundless benefits of weight-loss drugs under scrutiny Weight-loss jabs could halve obesity-linked cancer risks Israeli study Swiss study adds to concern about GLP-1 agonists link to vision issues US study finds serious side effects from weight-loss drugs

More treatment options still need to be explored

The market growth of this segment is can be linked to rising demand for safe and effective medications for type 2 diabetes and obesity, growing awareness of patients, rising disposable incomes, increased availability of drugs through widespread retail pharmacy network, government policies such as Pharmaceutical Benefits Scheme (PBS) and customer preference of purchasing drugs from pharmacies